154 results
8-K
EX-99.1
gtn1in9t7nulkh60dp
15 Feb 24
Net Revenue for Full Year 2023 Expected to be in the Range of $20 to $21 Million, an Increase of 84% to 93% Compared to Full Year 2022
4:45pm
8-K
EX-10.1
112d0brwz10x8q
28 Sep 23
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-10.1
fqdgwndy8w wbvezr
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm